Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

Study Overview
=================
Brief Summary
-----------------
This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

Official Title
-----------------
Visual Acuity, Refractive Predictability, and Patient Reported Quality of Vision in Subjects Implanted With a Trifocal IOL With Stable Mild Open-Angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery

Conditions
-----------------
Cataract, IOL, Glaucoma, Open-Angle

Intervention / Treatment
-----------------
* Procedure: Cataract surgery with implantation of trifocal IOL combined with trabecular scaffold


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or female subjects 45 years of age or older A visually significant cataract Diagnosis of mild OAG Vertical C/D ratio of less than or equal to 0.8 VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss) Medicated IOP 25 of less than or equal to mmHg on 1-3 medications If treatment naïve (before glaucoma treatment) IOP between 21 and 35 mmHg Glaucoma must be judged as stable by investigator based on review of subject medical records Stable VF at least 1 year prior to surgery Stable nerve fiber layer at least 1 year prior to surgery IOP stable on current medication regimen at least 3 months prior to surgery Shaffer grade of greater than III in all quadrants Potential of good best corrected visual acuity at distance in the investigator's judgement of at least 0.1 logMAR (20/25) postoperatively Able and willing to comply with follow up visits Understands and signs the informed consent Exclusion Criteria: Previous incisional glaucoma surgery or cilio-ablative surgery Prior laser trabeculoplasty within 90 days of surgery Pseudoexfoliative, angle closure, uveitic, congenital, traumatic, angle recession, or neovascular glaucoma. Moderate glaucoma with VF mean deviation between -6.00 dB and -12.00 dB Severe and/or progressive glaucoma defined as VF mean deviation worse than -12.00 dB Consistent worsening of visual field on review of subject medical records Consistent and progressive thinning of nerve fiber layer on review of subject medical records Uncontrolled IOP on maximum glaucoma medications Historically poor IOP control with medical therapy Severe focal notching of the optic nerve rim Expectation for future need of incisional glaucoma surgery Ocular pathology or other medical condition which, in the investigator's judgment places the subject at increased risk of complications or significant vision loss during study period. Ocular pathology that in the investigator's judgment may impact visual acuity postoperatively, i.e. significant ocular surface disease, corneal scarring, blepharitis, epiretinal membrane, macular degeneration, history of significant ocular trauma with sequela, etc. Pregnant or breastfeeding women Prior refractive surgery e.g. LASIK, RK, PRK, etc.

Ages Eligible for Study
-----------------
Minimum Age: 45 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Interventional Model Description: Prospective single arm open label descriptive case series
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Cataract Surgery with concurrent MIGS<br> | Procedure: Cataract surgery with implantation of trifocal IOL combined with trabecular scaffold<br>* Cataract surgery with implantation of the PanOptix IOL combined with minimally invasive glaucoma surgery utilizing the Hydrus Microstent<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean Photopic Monocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR |  | 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean Photopic Monocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (60 cm) logMAR |  | 3 months | 
| Mean Photopic Monocular Best Distance Corrected Near Visual Acuity (DCNVA) (40 cm) logMAR |  | 3 months | 
| Mean Photopic Monocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR |  | 3 months | 
| Mean Photopic Monocular Uncorrected Intermediate Visual Acuity (UCIVA) (60 cm) logMAR |  | 3 months | 
| Mean Photopic Monocular Uncorrected Near Visual Acuity (UCNVA) (40 cm) logMAR |  | 3 months | 
| Mean Photopic Binocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR |  | 3 months | 
| Mean Photopic Binocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (60 cm) logMAR |  | 3 months | 
| Mean Photopic Binocular Best Distance Corrected Near Visual Acuity (DCNVA) (40 cm) logMAR |  | 3 months | 
| Mean Photopic Binocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR |  | 3 months | 
| Mean Photopic Binocular Uncorrected Intermediate Visual Acuity (UCIVA) (60 cm) logMAR |  | 3 months | 
| Mean Photopic Binocular Uncorrected Near Visual Acuity (UCNVA) (40 cm) logMAR |  | 3 months | 
| Mean Photopic Binocular Best Corrected Distance Low Contrast Visual Acuity (25%) (4 meters) logMar |  | 3 months | 
| Mean Mesopic Binocular Best Corrected Distance Low Contrast Visual Acuity (25%) (4 meters) logMar |  | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
PanOptix, Trifocal IOL, Glaucoma, MIGS